Ifetroban

N/A

Report date: 2025/12/12 11:02:44
NME

Base Information

Drug NameIfetroban
Drug Alias Name伊非曲班ifetrobanumVasculanPortabanBoxaban +[13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsSolid tumoursPathologic ProcessesDrug Hypersensitivity +[19
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursPathologic ProcessesAutoimmune Diseases +[13
Inactive IndicationsDrug HypersensitivityCardiovascular DiseasesRespiratory Tract Diseases +[6

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG